Cited by 347Amyotrophic Lateral Sclerosis ResearchGenetic Neurodegenerative DiseasesAlzheimer's disease research and treatments

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations

Open access

Mackenzie, Ian R., Arzberger, Thomas, Kremmer, Elisabeth, Troost, Dirk, Lorenzl, Stefan, Mori, Kohji, Weng, Shih-Ming, Haass, Christian, Kretzschmar, Hans A., Edbauer, Dieter, Neumann, Manuela·2013·Acta Neuropathologica

DOI 10.1007/s00401-013-1181-y

Open this paper in CoChat — free account

Abstract

Hexanucleotide repeat expansion in C9ORF72 is the most common genetic cause of frontotemporal dementia and motor neuron disease. Recently, unconventional non-ATG translation of the expanded hexanucleotide repeat, resulting in the production and aggregation of dipeptide repeat (DPR) proteins (poly-GA, -GR and GP), was identified as a potential pathomechanism of C9ORF72 mutations. Besides accumulation of DPR proteins, the second neuropathological hallmark lesion in C9ORF72 mutation cases is the accumulation of TDP-43. In this study, we characterized novel monoclonal antibodies against poly-GA and performed a detailed analysis of the neuroanatomical distribution of DPR and TDP-43 pathology in a cohort of 35 cases with the C9ORF72 mutation that included a broad spectrum of clinical phenotypes. We found the pattern of DPR pathology to be highly consistent among cases regardless of the phenotype with high DPR load in the cerebellum, all neocortical regions (frontal, motor cortex and occipital) and hippocampus, moderate pathology in subcortical areas and minimal pathology in lower motor neurons. No correlation between DPR pathology and the degree of neurodegeneration was observed, while a good association between TDP-43 pathology with clinical phenotype and degeneration in key anatomical regions was present. Our data confirm that the presence of DPR pathology is intimately related to C9ORF72 mutations. The observed dissociation between DPR inclusion body load and neurodegeneration might suggest inclusion body formation as a potentially protective response to cope with soluble toxic DPR species. Moreover, our data imply that alterations due to the C9ORF72 mutation resulting in TDP-43 accumulation and dysmetabolism as secondary downstream effects likely play a central role in the neurodegenerative process in C9ORF72 pathogenesis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s00401-013-1181-y

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
Self-citation
Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936 · cited 4×
“The number of hexanucleotide repeats in the normal population ranges from 2 to 24 [13, 14, 17, 31, 39], whereas up to several thousand repeats (range 700–4,400 repeats) are described in the pathologically expanded allele as estimated by Southern blot analysis [5, 13, 14].”
BackgroundMethodInfluentialSelf-citation
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
Nelson, P. T., Alafuzoff, I., Bigio, E. H., Bouras, C., Braak, H., Cairns, N. J., Castellani, R. J., Crain, B. J., Davies, P., Tredici, K. D., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825018f7 · Cited by 2,050 · cited 1×
“Based on the observations that there is sometimes only poor correlation between the neuropathological hallmark lesions seen with neurodegeneration or phenotype, with the most prominent examples perhaps being the rather poor association of amyloid beta load with cognitive impairments [27] and intranuclear inclusions in…”
BackgroundSelf-citation
Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death
Arrasate, M., Mitra, S., Schweitzer, E. S., Segal, M. R., & Finkbeiner, S. (2004) · Nature · doi:10.1038/nature02998 · Cited by 1,979
The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS
Mori, K., Weng, S., Arzberger, T., May, S., Rentzsch, K., Kremmer, E., Schmid, B., Kretzschmar, H. A., Cruts, M., Broeckhoven, C. V., et al. (2013) · Science · doi:10.1126/science.1232927 · Cited by 1,248
Self-citation
Unconventional Translation of C9ORF72 GGGGCC Expansion Generates Insoluble Polypeptides Specific to c9FTD/ALS
Ash, P. E. A., Bieniek, K. F., Gendron, T. F., Caulfield, T. R., Lin, W.-L., DeJesus‐Hernandez, M., van Blitterswijk, M., Jansen‐West, K. R., Paul, J. W., Rademakers, R., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.004 · Cited by 1,127
A harmonized classification system for FTLD-TDP pathology
Mackenzie, I. R., Neumann, M., Baborie, A., Sampathu, D. M., du Plessis, D., Jaros, E., Perry, R. H., Trojanowski, J. Q., Mann, D. M. A., & Lee, V. M. ‐. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0845-8 · Cited by 1,042
Self-citation
Pathological TDP‐43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations
Mackenzie, I. R. A., Bigio, E. H., Ince, P. G., Geser, F., Neumann, M., Cairns, N. J., Kwong, L. K., Forman, M. S., Ravits, J., Stewart, H., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21147 · Cited by 992
Self-citation
Non-ATG–initiated translation directed by microsatellite expansions
Zu, T., Gibbens, B. B., Doty, N. S., Gomes-Pereira, M., Huguet-Lachon, A., Stone, M. D., Margolis, J., Peterson, M., Markowski, T. W., Ingram, M. A. C., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013343108 · Cited by 928

Show all 41 references

Sorted by citations

Items 101–200 of 347

Early dipeptide repeat pathology in a frontotemporal dementia kindred with C9ORF72 mutation and intellectual disability
Proudfoot, M. J., Gutowski, N. J., Edbauer, D., Hilton, D. A., Stephens, M., Rankin, J., & Mackenzie, I. R. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1245-7 · Cited by 79
Self-citation
Neurodegeneration in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9orf72 is linked to TDP‐43 pathology and not associated with aggregated forms of dipeptide repeat proteins
Davidson, Y., Robinson, A. C., Liu, X., Wu, D., Troakes, C., Rollinson, S., Masuda‐Suzukake, M., Suzuki, G., Nonaka, T., Shi, J., et al. (2016) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12292 · Cited by 77
Insights into the pathogenic mechanisms of chromosome 9 open reading frame 72 (C9orf72) repeat expansions
Todd, T. W., & Petrucelli, L. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13623 · Cited by 73
Impaired protein degradation in FTLD and related disorders
Götzl, J. K., Lang, C. M., Haass, C., & Capell, A. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.04.008 · Cited by 75
Self-citation
Glycine-alanine dipeptide repeat protein contributes to toxicity in a zebrafish model of C9orf72 associated neurodegeneration
Ohki, Y., Wenninger-Weinzierl, A., Hruscha, A., Asakawa, K., Kawakami, K., Haass, C., Edbauer, D., & Schmid, B. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0146-8 · Cited by 75
Self-citation
Cell‐to‐cell transmission of C9orf72 poly‐(Gly‐Ala) triggers key features of ALS/FTD
Khosravi, B., LaClair, K. D., Riemenschneider, H., Zhou, Q., Frottin, F., Mareljic, N., Czuppa, M., Farny, D., Hartmann, H., Michaelsen, M., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2019102811 · Cited by 70
Self-citation
C9orf72 promoter hypermethylation is neuroprotective
McMillan, C. T., Russ, J., Wood, E. M., Irwin, D. J., Grossman, M., McCluskey, L. F., Elman, L. B., Deerlin, V. M. V., & Lee, E. B. (2015) · Neurology · doi:10.1212/wnl.0000000000001495 · Cited by 71
C9orf72 amyotrophic lateral sclerosis and frontotemporal dementia
Mizielinska, S., & Isaacs, A. M. (2014) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000130 · Cited by 73
Accumulation of dipeptide repeat proteins predates that of TDP ‐43 in frontotemporal lobar degeneration associated with hexanucleotide repeat expansions in C9ORF72 gene
Baborie, A., Griffiths, T. D., Jaros, E., Perry, R., McKeith, I. G., Burn, D. J., Masuda‐Suzukake, M., Hasegawa, M., Rollinson, S. J., Pickering-Brown, S. M., et al. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12178 · Cited by 73
Molecular Mechanisms of Neurodegeneration Related to C9orf72 Hexanucleotide Repeat Expansion
Leko, M. B., Župunski, V., Kirincich, J., Smilović, D., Hortobágyi, T., Hof, P. R., & Šimić, G. (2019) · Behavioural Neurology · doi:10.1155/2019/2909168 · Cited by 73
Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features
Shaw, M. P., Higginbottom, A., McGown, A., Castelli, L. M., James, E. G., Hautbergue, G. M., Shaw, P. J., & Ramesh, T. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0629-7 · Cited by 72
Emerging Perspectives on Dipeptide Repeat Proteins in C9ORF72 ALS/FTD
Schmitz, A., Marques, J. P., Oertig, I., Maharjan, N., & Saxena, S. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.637548 · Cited by 70
Frontotemporal dementia
Deleon, J., & Miller, B. L. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64076-5.00027-2 · Cited by 75
Ante mortem cerebrospinal fluid tau levels correlate with postmortem tau pathology in frontotemporal lobar degeneration
Irwin, D. J., Lleó, A., Xie, S. X., McMillan, C. T., Wolk, D. A., Lee, E. B., Van Deerlin, V. M., Shaw, L. M., Trojanowski, J. Q., & Grossman, M. (2017) · Annals of Neurology · doi:10.1002/ana.24996 · Cited by 67
Congenic expression of poly-GA but not poly-PR in mice triggers selective neuron loss and interferon responses found in C9orf72 ALS
LaClair, K. D., Zhou, Q., Michaelsen, M., Wefers, B., Brill, M. S., Janjic, A., Rathkolb, B., Farny, D., Cygan, M., de Angelis, M. H., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02176-0 · Cited by 68
Self-citation
An amyloid-like cascade hypothesis for C9orf72 ALS/FTD
Edbauer, D., & Haass, C. (2015) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2015.10.009 · Cited by 69
Self-citation
DNA methylation age-acceleration is associated with disease duration and age at onset in C9orf72 patients
Zhang, M., Tartaglia, M. C., Moreno, D., Sato, C., McKeever, P. M., Weichert, A., Keith, J. L., Robertson, J., Zinman, L. H., & Rogaeva, E. A. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1713-y · Cited by 65
Active poly‐GA vaccination prevents microglia activation and motor deficits in a C9orf72 mouse model
Zhou, Q., Mareljic, N., Michaelsen, M., Parhizkar, S., Heindl, S., Nuscher, B., Farny, D., Czuppa, M., Schludi, C., Graf, A., et al. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201910919 · Cited by 64
Self-citation
Gel‐like inclusions of C‐terminal fragments of TDP‐43 sequester stalled proteasomes in neurons
Riemenschneider, H., Guo, Q., Bader, J. M., Frottin, F., Farny, D., Kleinberger, G., Haass, C., Mann, M., Hartl, F. U., Baumeister, W. P., et al. (2022) · EMBO Reports · doi:10.15252/embr.202153890 · Cited by 67
Self-citation
Poly-glycine–alanine exacerbates C9orf72 repeat expansion-mediated DNA damage via sequestration of phosphorylated ATM and loss of nuclear hnRNPA3
Nihei, Y., Bavarian Brain Banking Alliance, Mori, K., Werner, G., Arzberger, T., Zhou, Q., Khosravi, B., Japtok, J., Hermann, A., Sommacal, A., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02082-0 · Cited by 64
Self-citation
Progranulin reduces insoluble TDP-43 levels, slows down axonal degeneration and prolongs survival in mutant TDP-43 mice
Beel, S., Herdewyn, S., Fazal, R., Decker, M. D., Moisse, M., Robberecht, W., Bosch, L. V. D., & Damme, P. V. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0288-y · Cited by 63
Protein Quality Control and the Amyotrophic Lateral Sclerosis/Frontotemporal Dementia Continuum
Shahheydari, H., Ragagnin, A., Walker, A. K., Toth, R. P., Vidal, M., Jagaraj, C. J., Perri, E. R., Konopka, A., Sultana, J. M., & Atkin, J. D. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00119 · Cited by 61
RNA-mediated toxicity in C9orf72 ALS and FTD
McEachin, Z. T., Parameswaran, J., Raj, N., Bassell, G. J., & Jiang, J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105055 · Cited by 63
Genetic models of C9orf72: what is toxic?
Moens, T. G., Partridge, L., & Isaacs, A. M. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.01.006 · Cited by 57
Repeat-associated non-AUG (RAN) translation: insights from pathology
Báñez-Coronel, M., & Ranum, L. P. W. (2019) · Laboratory Investigation · doi:10.1038/s41374-019-0241-x · Cited by 56
TDP-43 pathology and cognition in ALS
Prudlo, J., König, J., Schuster, C., Kasper, E., Büttner, A., Teipel, S. J., & Neumann, M. (2016) · Neurology · doi:10.1212/wnl.0000000000003062 · Cited by 55
Self-citation
C9orf72: At the intersection of lysosome cell biology and neurodegenerative disease
Amick, J., & Ferguson, S. M. (2017) · Traffic · doi:10.1111/tra.12477 · Cited by 58
UBQLN2-HSP70 axis reduces poly-Gly-Ala aggregates and alleviates behavioral defects in the C9ORF72 animal model
Zhang, K., Ailian, W., Zhong, K., Qi, S., Chen, W., Shu, X., Tu, W.-Y., Xu, W., Xia, C., Xiao, Y., et al. (2021) · Neuron · doi:10.1016/j.neuron.2021.04.023 · Cited by 54
New developments of biofluid‐based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia
del Campo, M., Zetterberg, H., Gandy, S., Onyike, C. U., Oliveira, F., Udeh‐Momoh, C., Lleó, A., Teunissen, C. E., & Pijnenburg, Y. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12643 · Cited by 52
Old versus New Mechanisms in the Pathogenesis of ALS
Rossi, S., Cozzolino, M., & Carrı̀, M. T. (2016) · Brain Pathology · doi:10.1111/bpa.12355 · Cited by 55
dCas13-mediated translational repression for accurate gene silencing in mammalian cells
Apostolopoulos, A., Kawamoto, N., Chow, S. Y. A., Tsuiji, H., Ikeuchi, Y., Shichino, Y., & Iwasaki, S. (2024) · Nature Communications · doi:10.1038/s41467-024-46412-7 · Cited by 52
Amyotrophic lateral sclerosis caused by hexanucleotide repeat expansions in C9orf72: from genetics to therapeutics
Mizielinska, S., Hautbergue, G. M., Gendron, T. F., van Blitterswijk, M., Hardiman, O. M., Ravits, J., Isaacs, A. M., & Rademakers, R. (2025) · The Lancet Neurology · doi:10.1016/s1474-4422(25)00026-2 · Cited by 54
Mouse Models of C9orf72 Hexanucleotide Repeat Expansion in Amyotrophic Lateral Sclerosis/ Frontotemporal Dementia
Batra, R., & Lee, C. W. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00196 · Cited by 63
Unconventional features of C9ORF72 expanded repeat in amyotrophic lateral sclerosis and frontotemporal lobar degeneration
Vatovec, S., Kovanda, A., & Rogelj, B. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.04.015 · Cited by 53
Matrin 3 Is a Component of Neuronal Cytoplasmic Inclusions of Motor Neurons in Sporadic Amyotrophic Lateral Sclerosis
Tada, M., Doi, H., Koyano, S., Kubota, S., Fukai, R., Hashiguchi, S., Hayashi, N., Kawamoto, Y., Kunii, M., Tanaka, K., et al. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.10.007 · Cited by 47
C9ORF72 dipeptide repeat poly-GA inclusions promote intracellular aggregation of phosphorylated TDP-43
Nonaka, T., Masuda‐Suzukake, M., Hosokawa, M., Shimozawa, A., Hirai, S., Okado, H., & Hasegawa, M. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy174 · Cited by 53
Synaptic localization of C9orf72 regulates post-synaptic glutamate receptor 1 levels
Xiao, S., McKeever, P. M., Lau, A., & Robertson, J. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0812-5 · Cited by 50
Astrocytes and Microglia as Potential Contributors to the Pathogenesis of C9orf72 Repeat Expansion-Associated FTLD and ALS
Rostalski, H., Leskelä, S., Huber, N., Katisko, K., Cajanus, A., Solje, E., Marttinen, M., Natunen, T., Remes, A. M., Hiltunen, M. O., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00486 · Cited by 47
Blood-spinal cord barrier leakage is independent of motor neuron pathology in ALS
Waters, S., Dieriks, B. V., Swanson, M. E. V., Zhang, Y., Grimsey, N. L., Murray, H. C., Turner, C. P., Waldvogel, H. J., Faull, R. L. M., An, J., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01244-0 · Cited by 48
Reduced hnRNPA3 increases C9orf72 repeat RNA levels and dipeptide‐repeat protein deposition
Mori, K., Nihei, Y., Arzberger, T., Zhou, Q., Mackenzie, I. R., Hermann, A., Hanisch, F., Bavarian Brain Banking Alliance, Kamp, F., Nuscher, B., et al. (2016) · EMBO Reports · doi:10.15252/embr.201541724 · Cited by 47
Self-citation
High-throughput screening yields several small-molecule inhibitors of repeat-associated non-AUG translation
Green, K. M., Sheth, U., Flores, B. N., Wright, S. E., Sutter, A. B., Kearse, M. G., Barmada, S. J., Ivanova, M. I., & Todd, P. K. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.009951 · Cited by 45
Synaptic dysfunction induced by glycine‐alanine dipeptides in C9orf72‐ALS/FTD is rescued by SV2 replenishment
Jensen, B. K., Schuldi, M. H., McAvoy, K., Russell, K. A., Boehringer, A. V., Curran, B. M., Krishnamurthy, K., Wen, X., Westergard, T., Ma, L., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201910722 · Cited by 51
Self-citation
Regulated cell death and its role in Alzheimer’s disease and amyotrophic lateral sclerosis
Thal, D. R., Gawor, K., & Moonen, S. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02722-0 · Cited by 50
RAN translation and frameshifting as translational challenges at simple repeats of human neurodegenerative disorders
Wojciechowska, M., Olejniczak, M., Galka-Marciniak, P., Jazurek, M., & Krzyżosiak, W. J. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku794 · Cited by 45
The Skeletal Muscle Emerges as a New Disease Target in Amyotrophic Lateral Sclerosis
Pikatza‐Menoio, O., Elicegui, A., Bengoetxea, X., Naldaiz‐Gastesi, N., de Munaín, A. L., Gereñu, G., Gil-Bea, F. J., & Alonso‐Martín, S. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11070671 · Cited by 50
Neuroimaging in genetic frontotemporal dementia and amyotrophic lateral sclerosis
Häkkinen, S., Chu, S. A., & Lee, S. E. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105063 · Cited by 42
Prevalence of brain and spinal cord inclusions, including dipeptide repeat proteins, in patients with the C 9 ORF 72 hexanucleotide repeat expansion: a systematic neuropathological review
Schipper, L. J., Raaphorst, J., Aronica, E., Baas, F., de Haan, R. J., de Visser, M., & Troost, D. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12284 · Cited by 51
Self-citation
Repeat-Associated Non-AUG Translation and Its Impact in Neurodegenerative Disease
Kearse, M. G., & Todd, P. K. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0292-z · Cited by 43
Pathogenic determinants and mechanisms of ALS/FTD linked to hexanucleotide repeat expansions in the C9orf72 gene
Wen, X., Westergard, T., Pasinelli, P., & Trotti, D. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.09.007 · Cited by 45
eIF4B and eIF4H mediate GR production from expanded G4C2 in a Drosophila model for C9orf72-associated ALS
Goodman, L. D., Prudencio, M., Srinivasan, A. R., Rifai, O. M., Lee, V. M. ‐., Petrucelli, L., & Bonini, N. M. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0711-9 · Cited by 46
Soluble and insoluble dipeptide repeat protein measurements in C9orf72-frontotemporal dementia brains show regional differential solubility and correlation of poly-GR with clinical severity
Quaegebeur, A., Glaria, I., Lashley, T., & Isaacs, A. M. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01036-y · Cited by 46
The imaging signature of C9orf72 hexanucleotide repeat expansions: implications for clinical trials and therapy development
Shing, S. L. H., McKenna, M. C., Siah, W. F., Chipika, R. H., Hardiman, O. M., & Bede, P. (2021) · Brain Imaging and Behavior · doi:10.1007/s11682-020-00429-w · Cited by 43
Modelling amyotrophic lateral sclerosis in rodents
Todd, T. W., & Petrucelli, L. (2022) · Nature reviews. Neuroscience · doi:10.1038/s41583-022-00564-x · Cited by 44
Clinicopathologic report of ocular involvement in ALS patients with C9orf72 mutation
Fawzi, A. A., Simonett, J. M., Purta, P., Moss, H. E., Lowry, J., Deng, H., Siddique, N., Sufit, R. L., Bigio, E. H., Volpe, N. J., et al. (2014) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.951941 · Cited by 41
Survival and Prognostic Factors in C9orf72 Repeat Expansion Carriers
Glasmacher, S. A., Wong, C., Pearson, I., & Pal, S. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.3924 · Cited by 43
Repeat-Associated Non-ATG Translation in Neurological DiseasesPreprint
Zu, T., Pattamatta, A., & Ranum, L. P. W. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a033019 · Cited by 43
Prospective natural history study of C9orf72 ALS clinical characteristics and biomarkers
Cammack, A. J., Atassi, N., Hyman, T. S., van den Berg, L. H., Harms, M. B., Baloh, R. H., Brown, R. H., van Es, M. A., Veldink, J. H., de Vries, B. S., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000008359 · Cited by 46
The Development of C9orf72-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Disorders
Yang, Q., Jiao, B., & Shen, L. H. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.562758 · Cited by 43
Pathogenic Mechanisms and Therapy Development for C9orf72 Amyotrophic Lateral Sclerosis/Frontotemporal Dementia
Jiang, J., & Ravits, J. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00797-2 · Cited by 44
RNA-mediated pathogenic mechanisms in polyglutamine diseases and amyotrophic lateral sclerosis
Chan, H. Y. E. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00431 · Cited by 39
RNA Misprocessing in C9orf72-Linked Neurodegeneration
Barker, H., Niblock, M., Lee, Y., Shaw, C. E., & Gallo, J. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00195 · Cited by 45
Nuclear localized C9orf72-associated arginine-containing dipeptides exhibit age-dependent toxicity in C. elegans
Rudich, P. D., Snoznik, C., Watkins, S. C., Monaghan, J., Pandey, U. B., & Lamitina, S. T. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx372 · Cited by 41
Progranulin in neurodegenerative dementia
Wang, X., Zeng, P. H., Fang, Y., Zhang, T., & Tian, Q. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15378 · Cited by 39
Unstable repeat expansions in neurodegenerative diseases: nucleocytoplasmic transport emerges on the scene
Loureiro, J. R., Oliveira, C. L., & Silveira, I. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.12.007 · Cited by 38
Viral delivery of C9ORF72 hexanucleotide repeat expansions in mice lead to repeat length dependent neuropathology and behavioral deficits.
Herranz-Martín, S., Chandran, J. S., Lewis, K. E. A., Mulcahy, P. J., Higginbottom, A., Walker, C., y Valenzuela, I. M.-P., Jones, R. A., Coldicott, I., Iannitti, T., et al. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.029892 · Cited by 39
An interaction between synapsin and C9orf72 regulates excitatory synapses and is impaired in ALS/FTD
Bauer, C. S., Cohen, R. N., Sironi, F. M., Livesey, M. R., Gillingwater, T. H., Highley, J. R., Fillingham, D. J., Coldicott, I., Smith, E. F., Gibson, Y., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02470-z · Cited by 37
Neurochemical biomarkers in amyotrophic lateral sclerosis
Verde, F., Silani, V., & Otto, M. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000744 · Cited by 36
Disruption of nuclear speckle integrity dysregulates RNA splicing in C9ORF72-FTD/ALS
Wu, R., Ye, Y., Dong, D., Zhang, Z., Wang, S., Li, Y., Wright, N., Redding‐Ochoa, J., Chang, K., Xu, S., et al. (2024) · Neuron · doi:10.1016/j.neuron.2024.07.025 · Cited by 33
Drosha Inclusions Are New Components of Dipeptide-Repeat Protein Aggregates in FTLD-TDP and ALSC9orf72Expansion Cases
Porta, S., Kwong, L. K., Trojanowski, J. Q., & Lee, V. M. ‐. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000182 · Cited by 34
Biomarkers for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Associated With Hexanucleotide Expansion Mutations in C9orf72
Floeter, M. K., & Gendron, T. F. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.01063 · Cited by 33
Mechanisms of Immune Activation by c9orf72-Expansions in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Trageser, K. J., Smith, C., Herman, F. J., Ono, K., & Pasinetti, G. M. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01298 · Cited by 31
Co-expression of C9orf72 related dipeptide-repeats over 1000 repeat units reveals age- and combination-specific phenotypic profiles in Drosophila
West, R. J. H., Sharpe, J. L., Voelzmann, A., Munro, A. L., Hahn, I., Baines, R., & Pickering-Brown, S. M. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01028-y · Cited by 35
Interactome screening ofC9orf72dipeptide repeats reveals VCP sequestration and functional impairment by polyGA
Božič, J., Motaln, H., Pucer, A., Markič, L., Tripathi, P., Yamoah, A., Aronica, E., Lee, Y., Heilig, R., Fischer, R., et al. (2021) · Brain · doi:10.1093/brain/awab300 · Cited by 36
Systematic Screening of Ubiquitin/p62 Aggregates in Cerebellar Cortex Expands the Neuropathological Phenotype of the C9orf72 Expansion Mutation
Ramos‐Campoy, O., Polo, R. Á., Grau‐Rivera, O., Antonell, A., Clarimón, J., Rojas‐García, R., Charif, S., Santiago-Valera, V., Hernandez, I., Aguilar, M., et al. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly047 · Cited by 32
Faster Cortical Thinning and Surface Area Loss in Presymptomatic and Symptomatic C9orf72 Repeat Expansion Adult Carriers
Blanc, G. L., Pomerleau, V. J., McCarthy, J., Borroni, B., Swieten, J. C. V., Galimberti, D., Sánchez‐Valle, R., Laforce, R. J., Moreno, F., Synofzik, M., et al. (2020) · Annals of Neurology · doi:10.1002/ana.25748 · Cited by 32
Necrosome‐positive granulovacuolar degeneration is associated with TDP‐43 pathological lesions in the hippocampus of ALS/FTLD cases
Schoor, E. V., Koper, M. J., Ospitalieri, S., Dedeene, L., Tomé, S. O., Vandenberghe, R. R., Brenner, D., Otto, M., Weishaupt, J. H., Ludolph, A. C., et al. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12668 · Cited by 32
Autophagy and lysosomal pathways in nervous system disorders
Bingol, B. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.04.009 · Cited by 32
Translational control in brain pathologies: biological significance and therapeutic opportunities
Delaidelli, A., Jan, A., Herms, J. W., & Sorensen, P. H. B. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01971-8 · Cited by 31
Glial Cell Dysfunction in C9orf72-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Ghasemi, M., Keyhanian, K., & Douthwright, C. L. (2021) · Cells · doi:10.3390/cells10020249 · Cited by 35
Altered Phase Separation and Cellular Impact in C9orf72-Linked ALS/FTD
Solomon, D. A., Smikle, R., Reid, M. J., & Mizielinska, S. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.664151 · Cited by 33
Targeting the glycine-rich domain of TDP-43 with antibodies prevents its aggregation in vitro and reduces neurofilament levels in vivo
Riemenschneider, H., Simonetti, F., Sheth, U., Katona, E., Roth, S., Hutten, S., Farny, D., Michaelsen, M., Nuscher, B., Schmidt, M. K., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01592-z · Cited by 31
Self-citation
C9orf72-associated neurodegeneration in ALS-FTD: breaking new ground in ribosomal RNA and nucleolar dysfunction
Herrmann, D., & Parlato, R. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2806-1 · Cited by 29
Current and emerging ALS biomarkers: utility and potential in clinical trials
Taga, A., & Maragakis, N. J. (2018) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2018.1530987 · Cited by 29
C9ORF72 hexanucleotide repeat exerts toxicity in a stable, inducible motor neuronal cell model, which is rescued by partial depletion of Pten
Stopford, M. J., Higginbottom, A., Hautbergue, G. M., Cooper‐Knock, J., Mulcahy, P. J., Vos, K. J. D., Renton, A. E., Pliner, H. A., Calvo, A., Chiò, A., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx022 · Cited by 28
La accesibilidad de los portales web de las universidades públicas andaluzas
Balsells, L. A. C., González, J. C. G., Balsells, M. A. C., & Chamorro, V. A. P. (2017) · Revista española de Documentación Científica · doi:10.3989/redc.2017.2.1372 · Cited by 32
TDP-43 levels in the brain tissue of ALS cases with and without C9ORF72 or ATXN2 gene expansions
Yang, Y., Halliday, G. M., Kiernan, M. C., & Tan, R. H. (2019) · Neurology · doi:10.1212/wnl.0000000000008439 · Cited by 27
Intercellular transmission of pathogenic proteins in ALS: Exploring the pathogenic wave
Arnold, F. J., Nguyen, A., Bedlack, R., Bennett, C. L., & Spada, A. R. L. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106218 · Cited by 29
Coexisting Lewy body disease and clinical parkinsonism in frontotemporal lobar degeneration
Forrest, S. L., Crockford, D. R., Sizemova, A., McCann, H., Shepherd, C. E., McGeachie, A. B., Affleck, A. J., Carew‐Jones, F., Bartley, L., Kwok, J. B., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000007530 · Cited by 27
Frontotemporal lobar degeneration—building on breakthroughs
van der Zee, J., & Broeckhoven, C. V. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.270 · Cited by 25
RNA dependent suppression of C9orf72 ALS/FTD associated neurodegeneration by Matrin-3
Ramesh, N., Daley, E. L., Gleixner, A. M., Mann, J. R., Kour, S., Mawrie, D., Anderson, E. N., Kofler, J., Donnelly, C. J., Kiskinis, E., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01060-y · Cited by 25
No interaction between tau and TDP ‐43 pathologies in either frontotemporal lobar degeneration or motor neurone disease
Robinson, A., Thompson, J. C., Weedon, L., Rollinson, S. J., Pickering-Brown, S. M., Snowden, J. S., Davidson, Y. S., & Mann, D. M. A. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12155 · Cited by 25
C9ORF72 and UBQLN2 mutations are causes of amyotrophic lateral sclerosis in New Zealand: a genetic and pathologic study using banked human brain tissue
Scotter, E. L., Smyth, L. C. D., Bailey, J. W. T., Wong, C. H., de Majo, M., Vance, C. A., Synek, B. J., Turner, C. P., Pereira, J. A., Charleston, A., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.06.019 · Cited by 21
The RNA exosome complex degrades expanded hexanucleotide repeat RNA in C9orf72 FTLD/ALS
Kawabe, Y., Mori, K., Yamashita, T., Gotoh, S., & Ikeda, M. (2020) · The EMBO Journal · doi:10.15252/embj.2019102700 · Cited by 25
Self-citation
Neural Differentiation and spinal cord organoid generation from induced pluripotent stem cells (iPSCs) for ALS modelling and inflammatory screening
Guo, R., Chen, Y., Zhang, J., Zhou, Z., Feng, B., Du, X., Liu, X., Ma, J., & Cui, H. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03836-4 · Cited by 27
The porphyrin TMPyP4 inhibits elongation during the noncanonical translation of the FTLD/ALS-associated GGGGCC repeat in the C9orf72 gene
Mori, K., Gotoh, S., Yamashita, T., Uozumi, R., Kawabe, Y., Tagami, S., Kamp, F., Nuscher, B., Edbauer, D., Haass, C., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101120 · Cited by 23
Self-citation
Moderate intrinsic phenotypic alterations in C9orf72 ALS/FTD iPSC-microglia despite the presence of C9orf72 pathological features
Lorenzini, I., Alsop, E. B., Levy, J., Gittings, L. M., Lall, D., Rabichow, B. E., Moore, S. R., Pevey, R. S., Bustos, L. M., Burciu, C., et al. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1179796 · Cited by 34
[ 18 F]AV‐1451 binding is increased in frontotemporal dementia due to C9orf72 expansion
Bevan-Jones, W. R., Cope, T., Jones, S. P., Passamonti, L., Hong, Y. T., Fryer, T. D., Arnold, R. J., Coles, J., Aigbirhio, F. A., Patterson, K. E., et al. (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.631 · Cited by 26
Combined epigenetic/genetic study identified an ALS age of onset modifier
Zhang, M., Xi, Z., Sáez-Atiénzar, S., Chia, R., Moreno, D., Sato, C., Haghighi, M. M., Traynor, B. J., Zinman, L. H., & Rogaeva, E. A. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01183-w · Cited by 22
Antibody-Based Therapeutic Interventions for Amyotrophic Lateral Sclerosis: A Systematic Literature Review
Poulin-Brière, A., Rezaei, E., & Pozzi, S. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.790114 · Cited by 21
Genetic architecture of motor neuron diseases
Chaudhary, R., Agarwal, V., Rehman, M., Kaushik, A. S., & Mishra, V. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.120099 · Cited by 24

Authors: Mackenzie, I. R., Arzberger, T., Kremmer, E., Troost, D., Lorenzl, S., Mori, K., Weng, S.-M., Haass, C., Kretzschmar, H. A., Edbauer, D., & Neumann, M.
Affiliations: University of British Columbia (CA)
German Center for Neurodegenerative Diseases (DE)
Amsterdam UMC Location University of Amsterdam (NL)
Ludwig-Maximilians-Universität München (DE)
Adolf-Butenandt-Institut für Physiologische Chemie, Physikalische Biochemie und Zellbiologie (DE)
Institut für Neuropathologie (DE)
Corresponding author: Edbauer, Dieter
Neumann, Manuela
ORCID: Mackenzie, Ian R.
Lorenzl, Stefan
Mori, Kohji
Haass, Christian
Edbauer, Dieter
Neumann, Manuela
Venue: Acta Neuropathologica
Publisher: Springer Science and Business Media LLC
Published: 2013-10-06
Volume: 126
Issue: 6
Pages: 859-879
ISSN: 0001-6322 (ISSN-L)
1432-0533
DOI: 10.1007/s00401-013-1181-y
OpenAlex: W2092145129
Cited by: 345
References: 41
Citations by year: 2026: 8 · 2025: 17 · 2024: 17 · 2023: 19 · 2022: 16 · 2021: 31 · 2020: 31 · 2019: 36 · 2018: 36 · 2017: 43 · 2016: 26 · 2015: 34 · 2014: 29 · 2013: 2
FWCI: 19.25
Type: journal article
Language: en
Open access: green
hdl.handle.net
Licence: cc-by-nc-nd
www.springer.com/tdm (tdm)
Locations: Acta Neuropathologica (publishedVersion)
PubMed (publishedVersion)
Data Archiving and Networked Services (DANS) (submittedVersion)
cIRcle (University of British Columbia) (submittedVersion, cc-by-nc-nd)
Site cant be reached (submittedVersion)
DZNE Pub (submittedVersion)
Pure Amsterdam UMC (submittedVersion)
Open Collections
Funders: Canadian Institutes of Health Research (74580)
Topics: Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords: C9orf72 mutation, dipeptide repeat proteins, hexanucleotide repeat expansion, TDP-43 pathology, frontotemporal dementia, motor neuron disease, monoclonal antibodies, neurodegeneration, cerebellum, hippocampus, motor cortex, lower motor neurons, inclusion bodies, neuropathology
MeSH terms: C9orf72 Protein, Adult, Aged, Amyotrophic Lateral Sclerosis, Brain, DNA-Binding Proteins, Humans, Middle Aged, Mutation, Proteins, DNA Repeat Expansion, Frontotemporal Dementia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks